Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001096906-25-000819
Filing Date
2025-05-15
Accepted
2025-05-15 16:01:37
Documents
85
Period of Report
2025-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q lsfp_10q.htm   iXBRL 10-Q 1353387
2 CERTIFICATION lsfp_ex311.htm EX-31.1 9593
3 CERTIFICATION lsfp_ex312.htm EX-31.2 9644
4 CERTIFICATION lsfp_ex321.htm EX-32.1 4278
5 CERTIFICATION lsfp_ex322.htm EX-32.2 3503
  Complete submission text file 0001096906-25-000819.txt   8120296

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA lsfp-20250331.xsd EX-101.SCH 95539
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE lsfp-20250331_lab.xml EX-101.LAB 472840
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE lsfp-20250331_cal.xml EX-101.CAL 65283
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE lsfp-20250331_pre.xml EX-101.PRE 411230
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE lsfp-20250331_def.xml EX-101.DEF 265708
88 EXTRACTED XBRL INSTANCE DOCUMENT lsfp_10q_htm.xml XML 1463258
Mailing Address 14155 PINE ISLAND DRIVE JACKSONVILLE FL 32224
Business Address 14155 PINE ISLAND DRIVE JACKSONVILLE FL 32224 847-915-2446
LFTD PARTNERS INC. (Filer) CIK: 0001391135 (see all company filings)

EIN.: 870479286 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-52520 | Film No.: 25952401
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)